( October 1, 2026, 7:50 AM EDT) -- PHOENIX — The Arizona federal judge overseeing the multidistrict litigation involving C.R. Bard Inc.’s implanted port catheter (IPC) device denied a motion for summary judgment filed by C.R. Bard Inc. and related companies, clearing the way for the third bellwether trial in the MDL on product liability claims brought by a woman who alleges that a Bard PowerPort implanted for chemotherapy caused a bloodstream infection and sepsis....